2022 Q3 Form 10-Q Financial Statement

#000095017022014875 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $136.4M $124.8M $120.4M
YoY Change 24.13% 22.2% 36.3%
Cost Of Revenue $48.82M $46.35M $42.80M
YoY Change 15.79% 12.6% 10.24%
Gross Profit $87.57M $78.41M $77.63M
YoY Change 29.31% 28.69% 56.71%
Gross Profit Margin 64.2% 62.85% 64.46%
Selling, General & Admin $84.50M $81.31M $76.85M
YoY Change 29.58% 23.75% 67.94%
% of Gross Profit 96.5% 103.71% 98.99%
Research & Development $39.42M $44.93M $37.96M
YoY Change 16.15% 9.57% 71.43%
% of Gross Profit 45.01% 57.3% 48.89%
Depreciation & Amortization $4.886M $4.439M $4.182M
YoY Change 18.1% 29.0% 42.68%
% of Gross Profit 5.58% 5.66% 5.39%
Operating Expenses $123.9M $126.2M $114.8M
YoY Change 24.99% 18.3% 69.08%
Operating Profit -$36.35M -$47.84M -$37.17M
YoY Change 15.66% 4.48% 102.44%
Interest Expense $2.301M $837.0K $335.0K
YoY Change 3611.29% 884.71% 318.75%
% of Operating Profit
Other Income/Expense, Net -$976.0K -$1.173M -$425.0K
YoY Change 241.26% -2892.86% 5971.43%
Pretax Income -$35.02M -$48.17M -$37.26M
YoY Change 10.66% 5.5% 103.74%
Income Tax $1.014M $1.163M $1.008M
% Of Pretax Income
Net Earnings -$36.04M -$49.33M -$38.27M
YoY Change 11.05% 6.41% 105.05%
Net Earnings / Revenue -26.42% -39.55% -31.78%
Basic Earnings Per Share -$0.25 -$0.34 -$0.27
Diluted Earnings Per Share -$246.8K -$0.34 -$267.6K
COMMON SHARES
Basic Shares Outstanding 145.8M 144.8M 143.3M
Diluted Shares Outstanding 146.0M 144.8M 143.0M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $785.8M $783.1M $780.4M
YoY Change -3.71% -2.2% 177.93%
Cash & Equivalents $424.8M $380.0M $361.3M
Short-Term Investments $361.0M $403.1M $419.1M
Other Short-Term Assets $47.90M $42.99M $43.30M
YoY Change 30.8% 19.87% 24.43%
Inventory
Prepaid Expenses
Receivables $54.57M $57.42M $54.19M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $888.3M $883.6M $877.9M
YoY Change -0.05% -0.54% 149.97%
LONG-TERM ASSETS
Property, Plant & Equipment $38.91M $27.86M $26.40M
YoY Change 58.67% 20.88% 25.25%
Goodwill
YoY Change
Intangibles $8.985M $9.165M $9.703M
YoY Change -12.76% -11.33% -5.91%
Long-Term Investments
YoY Change
Other Assets $20.08M $18.24M $15.74M
YoY Change 78.87% 75.66% 67.35%
Total Long-Term Assets $67.97M $68.84M $68.96M
YoY Change 2.73% 5.54% 8.39%
TOTAL ASSETS
Total Short-Term Assets $888.3M $883.6M $877.9M
Total Long-Term Assets $67.97M $68.84M $68.96M
Total Assets $956.3M $952.4M $946.9M
YoY Change 0.15% -0.12% 128.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.18M $55.32M $53.90M
YoY Change 40.26% 32.78% 30.19%
Accrued Expenses $21.65M $24.56M $24.10M
YoY Change -18.62% 4.79% 47.83%
Deferred Revenue $116.6M $115.6M $106.8M
YoY Change 27.61% 20.5% 25.31%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $235.7M $224.3M $203.8M
YoY Change 29.92% 26.63% 29.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.54M $913.0K $955.0K
YoY Change 1914.49% 53.96% 53.29%
Total Long-Term Liabilities $11.54M $913.0K $955.0K
YoY Change 1914.49% 53.96% 53.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $235.7M $224.3M $203.8M
Total Long-Term Liabilities $11.54M $913.0K $955.0K
Total Liabilities $247.3M $236.6M $218.2M
YoY Change 24.34% 19.39% 22.15%
SHAREHOLDERS EQUITY
Retained Earnings -$612.4M -$576.4M -$527.0M
YoY Change 38.86% 41.07% 45.5%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.701M $4.701M $4.701M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $2.748M $2.748M $2.748M
Shareholders Equity $709.0M $715.8M $728.7M
YoY Change
Total Liabilities & Shareholders Equity $956.3M $952.4M $946.9M
YoY Change 0.15% -0.12% 128.26%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$36.04M -$49.33M -$38.27M
YoY Change 11.05% 6.41% 105.05%
Depreciation, Depletion And Amortization $4.886M $4.439M $4.182M
YoY Change 18.1% 29.0% 42.68%
Cash From Operating Activities $4.791M $857.0K -$38.26M
YoY Change -55.4% -115.72% 780.08%
INVESTING ACTIVITIES
Capital Expenditures -$3.826M -$4.376M -$4.561M
YoY Change -0.39% 28.4% 2.26%
Acquisitions
YoY Change
Other Investing Activities $42.91M $15.00M -$180.6M
YoY Change 19.2% -79.02% -318.85%
Cash From Investing Activities $39.09M $10.62M -$185.1M
YoY Change 21.54% -84.39% -337.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 913.0K 7.209M 4.027M
YoY Change -89.29% -98.64% -10.57%
NET CHANGE
Cash From Operating Activities 4.791M 857.0K -38.26M
Cash From Investing Activities 39.09M 10.62M -185.1M
Cash From Financing Activities 913.0K 7.209M 4.027M
Net Change In Cash 44.79M 18.69M -219.3M
YoY Change -12.9% -96.84% -380.51%
FREE CASH FLOW
Cash From Operating Activities $4.791M $857.0K -$38.26M
Capital Expenditures -$3.826M -$4.376M -$4.561M
Free Cash Flow $8.617M $5.233M -$33.70M
YoY Change -40.91% -356.27% -29919.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
126241000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
106712000
us-gaap Operating Expenses
OperatingExpenses
241041000
us-gaap Operating Expenses
OperatingExpenses
174610000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47835000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-45785000
us-gaap Operating Income Loss
OperatingIncomeLoss
-85005000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64146000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63144000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55586000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
43862000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
837000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
107253000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
85000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76475000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25726000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1172000
us-gaap Investment Income Interest
InvestmentIncomeInterest
165000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1173000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
42000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1598000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21846000
dei Local Phone Number
LocalPhoneNumber
963-9884
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
dei Trading Symbol
TradingSymbol
COUR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145763241
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
380005000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
580658000
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
403140000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
241117000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
189000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
105000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34396000
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
22496000
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
19666000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20494000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16494000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
883553000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
892331000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27862000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24725000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11510000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16321000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9165000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10091000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2061000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2061000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18239000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13381000
CY2022Q2 us-gaap Assets
Assets
952390000
CY2021Q4 us-gaap Assets
Assets
958910000
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
55323000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
49206000
CY2022Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
20876000
CY2021Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
23257000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16519000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18353000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8043000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8031000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
115581000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
94637000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7968000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
35000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7639000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
224310000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
201123000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8715000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11864000
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2665000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3851000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
913000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
559000
CY2022Q2 us-gaap Liabilities
Liabilities
236603000
CY2021Q4 us-gaap Liabilities
Liabilities
217397000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
dei Entity Central Index Key
EntityCentralIndexKey
0001651562
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40275
dei Entity Registrant Name
EntityRegistrantName
COURSERA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3560292
dei Entity Address Address Line1
EntityAddressAddressLine1
381 E. Evelyn Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
Mountain View
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94041
dei City Area Code
CityAreaCode
650
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148332771
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145584833
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144653979
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141906041
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1299173000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1235231000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2747938
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2747938
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
4701000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48171000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4701000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2318000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-252000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-576368000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-488766000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45658000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
715787000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85431000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
741513000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
952390000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
958910000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124754000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102089000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41004000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
82884000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50904000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34991000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245187000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190451000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
46348000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
41162000
us-gaap Cost Of Revenue
CostOfRevenue
89151000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57418000
us-gaap Cost Of Revenue
CostOfRevenue
79987000
CY2022Q2 us-gaap Gross Profit
GrossProfit
78406000
CY2021Q2 us-gaap Gross Profit
GrossProfit
60927000
us-gaap Gross Profit
GrossProfit
156036000
us-gaap Gross Profit
GrossProfit
110464000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44929000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63946000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1163000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
705000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2171000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1080000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-49334000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-46363000
us-gaap Profit Loss
ProfitLoss
-87602000
us-gaap Profit Loss
ProfitLoss
-65026000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144782220
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144782220
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14284000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131804121
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131804121
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143909469
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143909469
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86761169
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86761169
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-49334000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-46363000
us-gaap Net Income Loss
NetIncomeLoss
-87602000
us-gaap Net Income Loss
NetIncomeLoss
-65026000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-454000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2066000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-15000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49788000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46381000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89668000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65041000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
728685000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5035000
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2227000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4596000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29486000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-454000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-49334000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
715787000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
741513000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11485000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4852000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4596000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52713000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2066000
us-gaap Net Income Loss
NetIncomeLoss
-87602000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
715787000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-226089000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
462293000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
518835000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5720000
CY2021Q2 cour Adjustments To Additional Paid In Capital Vesting Of Early Exercise Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseStockOptions
21000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41010000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-46363000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
755409000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-221824000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
462293000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
518835000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5095000
cour Adjustments To Additional Paid In Capital Vesting Of Early Exercise Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExerciseStockOptions
42000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46820000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-15000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Other Noncash Expense
OtherNoncashExpense
493000
us-gaap Other Noncash Expense
OtherNoncashExpense
105000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
717000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
739000
us-gaap Net Income Loss
NetIncomeLoss
-65026000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23428000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11141000
cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
7266000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
cour Payments To Capitalized Internal Use Software Costs
PaymentsToCapitalizedInternalUseSoftwareCosts
6598000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-174489000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
755409000
us-gaap Profit Loss
ProfitLoss
-87602000
us-gaap Profit Loss
ProfitLoss
-65026000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8621000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6371000
us-gaap Share Based Compensation
ShareBasedCompensation
49483000
us-gaap Share Based Compensation
ShareBasedCompensation
44459000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-1020000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-319000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13522000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4124000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2507000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2716000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4462000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5274000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1151000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4347000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3136000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3191000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
19758000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
20639000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37400000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9800000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
180552000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
153981000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
146113000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11787000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14284000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4596000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
525284000
cour Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
295000
cour Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
6110000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4852000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11236000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
2061000
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
2548000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
382066000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
752197000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1475000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
874000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
533458000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-200653000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
669771000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582719000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82426000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
382066000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
752197000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
380005000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
749649000
cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
3230000
cour Share Based Compensation Capitalized As Internal Use Software
ShareBasedCompensationCapitalizedAsInternalUseSoftware
2361000
cour Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
0
cour Unpaid Deferred Offering Costs
UnpaidDeferredOfferingCosts
339000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
403140000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
241369000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
252000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.65
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q2 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
4606000
CY2021Q2 cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
3400000
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
780208000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—The preparation of these unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the fair value of common stock and stock-based awards; period of benefit for capitalized commissions; internal-use software costs; useful lives of long-lived assets; the carrying value of operating lease right-of-use assets; valuation of intangible assets and income tax expense, including the valuation of deferred tax assets and liabilities, among others.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—Financial instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company invests only in high-credit-quality instruments and maintains its cash equivalents and marketable securities in fixed-income securities. The Company places its cash primarily with domestic financial institutions that are federally insured within statutory limits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer. For the three and six months ended June 30, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company did not have any customers that accounted for more than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s revenue. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customer that accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of its net accounts receivable balance that has since been collected within typical business terms. As of December 31, 2021, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customer accounted for more than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">of the Company’s net accounts receivable balance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
52940000
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
22286000
CY2021Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
39976000
CY2022Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4478000
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
12110000
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
745000
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
57418000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
34396000
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
40721000
CY2022Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
118246000
CY2021Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
98488000
CY2021Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
80642000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
118246000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98488000
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
80642000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
70323000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
56001000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
276148000
CY2022Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3003000
CY2021Q2 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
1884000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
405458000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2318000
cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
7099000
cour Commissions And Related Payroll Tax Expenditures
CommissionsAndRelatedPayrollTaxExpenditures
5692000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
5747000
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3550000
CY2022Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
11107000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9165000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14348000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4257000
CY2021Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
8823000
CY2022Q2 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
9761000
CY2021Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
8817000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
736953000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
241117000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
405458000
CY2022Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
403140000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
241369000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
241117000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
403140000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2318000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
241117000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
252000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60296000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49841000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32434000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25116000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27862000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24725000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14725000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5560000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1321000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2618000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10091000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
660000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
576000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1303000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2627000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2099000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1003000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46363000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
433000
CY2022Q2 cour Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
67000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9165000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.024
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.015
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.025
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.017
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87602000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-65026000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
7781000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
7781000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
44744000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
16803000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27505000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39175000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49483000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44459000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
38220000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49334000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19489493
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23000872
CY2022Q2 cour Share Based Compensation Arrangement By Share Based Payment Award Rsus Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRsusOutstanding
12485154
CY2021Q4 cour Share Based Compensation Arrangement By Share Based Payment Award Rsus Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRsusOutstanding
7387288
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
20153991
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
16905525
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
52128638
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
47293685
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144782220
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144782220
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131804121
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131804121
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143909469
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143909469
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86761169
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86761169
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190451000
us-gaap Gross Profit
GrossProfit
110464000
CY2022Q2 cour Segment Gross Profit Loss
SegmentGrossProfitLoss
93192000
CY2021Q2 cour Segment Gross Profit Loss
SegmentGrossProfitLoss
71614000
CY2022Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
46500000
cour Segment Gross Profit Loss
SegmentGrossProfitLoss
182731000
cour Segment Gross Profit Loss
SegmentGrossProfitLoss
129811000
CY2022Q2 cour Platform And Support Costs
PlatformAndSupportCosts
10270000
CY2021Q2 cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
10687000
cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
26695000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124754000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124754000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102089000
cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
19347000
CY2022Q2 us-gaap Gross Profit
GrossProfit
78406000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102089000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245187000
CY2021Q2 us-gaap Gross Profit
GrossProfit
60927000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32092358
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32092358
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34185457
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34185457
CY2022Q2 cour Sublease Commencement Date
SubleaseCommencementDate
2022-06-01
CY2022Q2 cour Sublease Expiration Date
SubleaseExpirationDate
2024-10-31
CY2022Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2304000
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
687000
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1354000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021Q2 cour Platform And Support Costs
PlatformAndSupportCosts
7066000
cour Platform And Support Costs
PlatformAndSupportCosts
18163000
cour Platform And Support Costs
PlatformAndSupportCosts
13376000
CY2022Q2 cour Segment Share Based Compensation
SegmentShareBasedCompensation
812000
CY2021Q2 cour Segment Share Based Compensation
SegmentShareBasedCompensation
903000
cour Segment Share Based Compensation
SegmentShareBasedCompensation
1389000
cour Segment Share Based Compensation
SegmentShareBasedCompensation
1010000
CY2022Q2 cour Total Reconciliation Item Of Segment Gross Profit To Gross Profit
TotalReconciliationItemOfSegmentGrossProfitToGrossProfit
14786000
us-gaap Gross Profit
GrossProfit
156036000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
245187000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190451000
us-gaap Concentration Risk Benchmark Description
ConcentrationRiskBenchmarkDescription
No single country other than the United States represented 10% or more of the Company’s total revenue during the three and six months ended June 30, 2022 and 2021.
CY2022Q2 us-gaap Noncurrent Assets
NoncurrentAssets
39372000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
41046000

Files In Submission

Name View Source Status
0000950170-22-014875-index-headers.html Edgar Link pending
0000950170-22-014875-index.html Edgar Link pending
0000950170-22-014875.txt Edgar Link pending
0000950170-22-014875-xbrl.zip Edgar Link pending
cour-20220630.htm Edgar Link pending
cour-20220630.xsd Edgar Link pending
cour-20220630_cal.xml Edgar Link unprocessable
cour-20220630_def.xml Edgar Link unprocessable
cour-20220630_htm.xml Edgar Link completed
cour-20220630_lab.xml Edgar Link unprocessable
cour-20220630_pre.xml Edgar Link unprocessable
cour-ex10_1.htm Edgar Link pending
cour-ex31_1.htm Edgar Link pending
cour-ex31_2.htm Edgar Link pending
cour-ex32_1.htm Edgar Link pending
cour-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img225266043_0.jpg Edgar Link pending
img225266043_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending